G. Angeletti

Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses

A. Faggiano, A. Colao, G. Lombardi, 2011, Journal of Endocrinological Investigation.